Amid drug pricing debate, feds reveal effort to crack down on 'incremental' patents

[cafead]

via Watch out, pharma—the federal government has its eye on add-on drug patents that can lead to higher prices. In a new effort, the FDA and the U.S. Patent and Trademark Office (PTO) are teaming up to take a close look at patenting procedures.

article source